港股通 “新秀” 獲資金熱捧 港股市場稀缺優質標的迎重大機遇

智通財經
2023.03.13 23:20
3 月 13 日，港股艾美疫苗、智雲健康、嗶哩嗶哩-W、衞龍、名創優品等港股通 “新秀” 獲資金熱捧，股價持續拉昇。其中，艾美疫苗盤初漲幅一度超 180%，股價創上市以來新高；截至收盤，艾美疫苗漲幅達 65.68%，也創下其上市以來最大單日漲幅。嗶哩嗶哩-W 昨日獲滬市港股通增持 3.38 億港元。業內人士認為，隨着互聯互通機制不斷優化，相關個股引來資金 “活水”。本次互聯互通股票標的擴容，標誌着資本市場雙向開放進入新階段，將為境外資金參與 A 股市場提供更大的參與空間，同時也為南向資金投資港股及配置境外資產提供便利。
Source: 智通財經 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.